21:08 , Aug 2, 2018 |  BC Extra  |  Company News

Management tracks: Omeros, EdiGene

Omeros Corp. (NASDAQ:OMER) hired Eckhard Leifke as CMO and VP of clinical development. He was global project head/VP of early project and external opportunities - cardiovascular and metabolism and global head/VP of late-stage development diabetes...
22:18 , Aug 1, 2018 |  BC Extra  |  Company News

Management tracks: Hologic, Tricidia

Hologic Inc. (NASDAQ:HOLX) said Bob McMahon has departed as CFO to become CFO at Agilent Technologies Inc. (NYSE:A). The diagnostics company promoted Chief Accounting Officer Karleen Oberton to CFO. Metabolic acidosis play Tricida Inc. (NASDAQ:TCDA) hired...
19:30 , Jun 15, 2018 |  BC Week In Review  |  Clinical News

FDA approves Keytruda in cervical cancer, PMBCL

Merck & Co. Inc. (NYSE:MRK) said FDA granted accelerated approval to Keytruda pembrolizumab to treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy in patients whose tumors express PD-L1, with a...
22:05 , Apr 25, 2018 |  BC Extra  |  Company News

Management tracks: Urovant, Cue

Urology company Urovant Sciences, a subsidiary of Roivant Sciences GmbH (Basel, Switzerland), hired Cornelia Haag-Molkenteller as CMO, Michael McFadden as chief commercial officer, Bryan Smith as general counsel and Christine Ocampo as SVP and chief...
01:09 , Feb 16, 2018 |  BC Innovations  |  Strategy

Pfizer’s chemistry machine

With the goal of creating a step-change in the optimization of small molecules in discovery research, Pfizer Inc. has built a continuous flow machine that rapidly tests thousands of chemical reactions using submilligram quantities of...
22:29 , Jun 15, 2017 |  BC Extra  |  Company News

Twist, BioBricks launching open gene forum

Twist Bioscience Corp. (San Francisco, Calif.) and BioBricks Foundation (San Francisco, Calif.) partnered to create an open online forum for researchers to suggest and vote on genes for manufacture. BioBricks will pay for synthesis of...
23:44 , May 10, 2017 |  BC Extra  |  Company News

Management tracks

RNA company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced several additions. The biotech named Alan Eisenberg VP of global public policy and government relations; Theresa Heggie SVP and head of Europe and Canada; Peter Smith SVP of...
22:07 , Mar 17, 2017 |  BioCentury  |  Tools & Techniques

Calibrating PD-L1

Flagship Biosciences Inc.’s Computational Tissue Analysis platform won’t provide a common cutoff point across the five major assays used to measure PD-L1 expression. But it could calibrate the output so that results from one assay...
00:34 , Feb 23, 2017 |  BC Extra  |  Clinical News

Roche PD-L1 assay not concordant with others

A study led by scientists at AstraZeneca plc (LSE:AZN; NYSE:AZN) suggests that while three separate companion diagnostics measuring PD-L1 expression may be interchangeable, a fourth test developed as a companion diagnostic for Roche (SIX:ROG; OTCQX:RHHBY)...
22:58 , Dec 14, 2016 |  BC Week In Review  |  Financial News

Molecular Assemblies completes venture financing

Molecular Assemblies raised $2.3 million in a seed round from Agilent Technologies Inc., Cavendish Impact Capital Fund, Eleven Two Capital, Keshif Ventures, Genomics Investment Syndicate, Newport Holdings and Alexandria Venture Investments. Molecular Assemblies Inc., San Diego,...